Radiation-induced Xerostomia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MeiraGTx
MeiraGTxNEW YORK, NY
1 program
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced XerostomiaN/A1 trial
Active Trials
NCT05060341Active Not RecruitingEst. Mar 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
MeiraGTxLong-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

Clinical Trials (1)

NCT05060341MeiraGTxLong-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

Start: Nov 2020Est. completion: Mar 2027
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space